<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Biological imaging by <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) using <z:chebi fb="0" ids="36939">18F</z:chebi>-2-fluoro-2-deoxy-<z:chebi fb="0" ids="4167">D-glucose</z:chebi> (FDG) has been widely used clinically for the detection of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and for early prediction of response to chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined the molecular mechanism underlying the detection of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> by FDG-PET </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIAL AND METHODS: In <z:hpo ids='HP_0000001'>all</z:hpo>, 37 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were examined with FDG-PET, and the maximal standardized uptake value (SUV) was calculated </plain></SENT>
<SENT sid="3" pm="."><plain>Using surgical tissue samples, we examined the expression levels of <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor alpha (HIF1α), a marker of tissue <z:mp ids='MP_0005039'>hypoxia</z:mp>; proliferative cellular nuclear antigen (PCNA), a marker of proliferation; and <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter (GLUT)1 and hexokinase (HK)2, protein of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake by using reverse transcriptase-polymerase chain reaction </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> except two <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> lesions showed increased uptake of FDG </plain></SENT>
<SENT sid="5" pm="."><plain>The mean SUV of FDG-PET was 12.0 ± 1.2 (±<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of GLUT1 and HK2 were significantly higher in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues than in the surrounding <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, to promote the upregulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake, the expressions of HIF1α and PCNA were induced to 2.6 and 3.3 times higher than that in the <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="8" pm="."><plain>However, the quantitative correlation analysis showed SUV was correlated with HIF1α expression but not with PCNA expression </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our molecular-based analysis suggested that FDG accumulation due to induction of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake proteins might be associated with the hypoxic environment in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> rather than the <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, for assessing the efficacy of chemotherapy using FDG-PET, we must keep in mind that SUV does not indicate the <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> directly </plain></SENT>
</text></document>